MD Anderson Cancer Center
Ovarian cancer screening with simple blood test – CNL
A simple blood test currently approved to detect ovarian cancer disease recurrence is full of new possibility. It may, one day, detect invasive, high-grade disease at its earliest, most curable stage. Listen to Karen Lu, M.D., professor and chair of  Gynecologic Oncology and Reproductive Medicine, as she details the findings, and what they could, one day, mean for women.
Loading the Audio Player...

Title: Ovarian cancer screening with simple blood test – CNL
Summary: A simple blood test currently approved to detect ovarian cancer disease recurrence is full of new possibility. It may, one day, detect invasive, high-grade disease at its earliest, most curable stage. Listen to Karen Lu, M.D., professor and chair of  Gynecologic Oncology and Reproductive Medicine, as she details the findings, and what they could, one day, mean for women.
Keywords: integratedComm, Communications - Integrated Media
Transcript: